載入...
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta(2)‐agonists (LABA) for adults with asthma
BACKGROUND: Poorly controlled asthma and preventable exacerbations place a significant strain on healthcare, often requiring additional medications, hospital stays or treatment in the emergency department. Long‐acting beta(2)‐agonists (LABA) are the preferred add‐on treatment for adults with asthma...
Na minha lista:
| 發表在: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Ltd
2015
|
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513433/ https://ncbi.nlm.nih.gov/pubmed/26031392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011438.pub2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|